Jurnal Farmasi Klinik - Best Practice (JFKlin)
Vol 1 No 1 (2022): Jurnal Farmasi Klinik - Base Practice

Evaluation Of The Use Of Cyclophosphamide In Children Diagnosed With Steroid Resistant Nephrotic Syndrome Treated In The 3rd Floor Treatment At Fatmawati Hospital

Satriani Sinukaban (Unknown)
Bobby Setiadi Darmawan (RSUP Fatmawati)



Article Info

Publish Date
10 Dec 2022

Abstract

A total of 32 children with nephrotic syndrome were treated with cyclophosphamide, the remissions and side effects that often occurred during therapy were counted. This research was conducted using a retrospective descriptive method. The results showed that the remission was 59.4%. The mean duration of the call to remission was 14 weeks and the mean dose of cyclophosphamide was 589 mg. As many as 59.4% of patients experienced no side effects, while 40.6% experienced side effects. Side effects that occurred included vomiting (3.1%); nausea (3.1%); hair loss (6.3%); nausea and vomiting (12.5%); vomiting and hair loss (6.3%); nausea and hair loss (6.3%); and nausea, vomiting, and hair loss (3.1%). Keywords: Steroid-Resistant Nephrotic Syndrome, Cyclophosphamide

Copyrights © 2022






Journal Info

Abbrev

jfklin

Publisher

Subject

Chemistry Health Professions Immunology & microbiology Medicine & Pharmacology Public Health

Description

Jurnal Farmasi Klinik - Base Practice (JFKlin) is a peer-reviewed journal published by RSUP Fatmawati. It focus on the field of health sciences with the specialty of pharmaceutical sciences, pharmaceutical services in hospitals and community. JFKlin has been published twice a year in Indonesian and ...